Givaudan, CH0010645932

Givaudan SA stock (CH0010645932): Shares drop 0.94% to 2,753 CHF amid earnings anticipation

12.05.2026 - 19:51:58 | ad-hoc-news.de

Givaudan SA shares fell 0.94% to 2,753 CHF on May 11, 2026, as the flavors and fragrances leader approaches its upcoming earnings release on May 14. US investors track the ADR (GVDNY) for exposure to global consumer trends.

Givaudan, CH0010645932
Givaudan, CH0010645932

Givaudan SA, a global leader in flavors and fragrances, saw its stock decline by 0.94% on May 11, 2026, closing at 2,753.00 CHF on the Swiss Exchange. The shares moved from 2,779.00 CHF, reflecting short-term pressure ahead of the company's earnings report scheduled for May 14, 2026, according to StockInvest.us as of May 11, 2026. The ADR (GVDNY) provides US investors access to this key player in the consumer goods supply chain.

As of: 12.05.2026

By the editorial team – specialized in equity coverage.

At a glance

  • Name: Givaudan SA
  • Sector/industry: Flavors and Fragrances
  • Headquarters/country: Switzerland
  • Core markets: Global (food, beverages, perfumes, cosmetics)
  • Key revenue drivers: Taste & Wellbeing, Fragrance
  • Home exchange/listing venue: Swiss Exchange (GIVN)
  • Trading currency: CHF

Official source

For first-hand information on Givaudan SA, visit the company’s official website.

Go to the official website

Givaudan SA: core business model

Givaudan SA develops, manufactures and sells flavor and fragrance compounds used in food, beverages, perfumes, cosmetics and household products. The company operates through two main divisions: Taste & Wellbeing, which focuses on savory, sweet, beverage and dairy flavors, and Fragrance, covering fine and consumer fragrances. Headquartered in Vernier, Switzerland, Givaudan serves over 100 countries with a portfolio emphasizing innovation and sustainability, according to its investor relations page as of May 2026.

The business model relies on R&D investment, with annual spending supporting proprietary technologies and nature-derived ingredients. Givaudan collaborates with major brands to create customized solutions, positioning it as a critical supplier in the fast-moving consumer goods sector.

Main revenue and product drivers for Givaudan SA

Taste & Wellbeing generated the bulk of revenue in recent periods, driven by demand for clean-label and plant-based flavors amid health trends. Fragrance benefits from premiumization in perfumes and personal care. Key products include natural extracts and biotech-derived ingredients, with growth in emerging markets offsetting mature region slowdowns, per financial summaries on Investing.com as of May 2026.

Revenue drivers include volume growth in Asia-Pacific and innovation in low/no-alcohol beverages. The lavender oil market, where Givaudan competes, is projected to reach US$287.3 million by 2033, highlighting sector tailwinds, according to openPR as of recent report.

Industry trends and competitive position

The flavors and fragrances industry faces rising demand for sustainable, natural ingredients amid regulatory pressures like EU green claims rules. Givaudan holds a top-tier position alongside rivals like IFF and Firmenich (now DSM-Firmenich), with strong pricing power from its innovation moat. US investors value its exposure to resilient consumer staples.

Why Givaudan SA matters for US investors

Givaudan SA's ADR (GVDNY) offers US investors indirect play on indispensable consumer trends like personalization in scents and functional foods. With significant North American revenue, the company benefits from US market dynamics, including premium beauty growth and health-focused snacking, making it relevant for portfolios tracking global supply chains.

Read more

Additional news and developments on the stock can be explored via the linked overview pages.

More news on this stockInvestor relations

Conclusion

Givaudan SA's recent 0.94% share price dip precedes key earnings on May 14, underscoring market focus on its growth trajectory in flavors and fragrances. While short-term trends show caution, the company's strong industry position and innovation pipeline support ongoing relevance. US investors monitor the ADR for consumer sector insights.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis Givaudan Aktien ein!

<b>So schätzen die Börsenprofis Givaudan Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | CH0010645932 | GIVAUDAN | boerse | 69316606 | bgmi